• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immediate in-hospital outcomes after percutaneous revascularization of acute myocardial infarction complicated by cardiogenic shock.急性心肌梗死合并心源性休克经皮血管重建术后的院内即时结局
World J Cardiol. 2023 Sep 26;15(9):439-447. doi: 10.4330/wjc.v15.i9.439.
2
Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.急性心肌梗合并需要静脉动脉体外膜肺氧合的晚期心源性休克患者中,罪犯血管血运重建与即刻多血管经皮冠状动脉介入治疗的比较。
J Am Heart Assoc. 2023 May 16;12(10):e029792. doi: 10.1161/JAHA.123.029792. Epub 2023 May 9.
3
Long-Term Mortality Comparison of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Culprit-Only or Multivessel Percutaneous Coronary Intervention.急性心肌梗死合并心源性休克患者接受仅针对罪犯血管或多支血管经皮冠状动脉介入治疗的长期死亡率比较
Cardiovasc Revasc Med. 2021 Jan;22:10-15. doi: 10.1016/j.carrev.2020.06.021. Epub 2020 Jun 18.
4
Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.编辑精选-急性心肌梗死并发心原性休克患者行即刻多支血管经皮冠状动脉介入治疗与罪犯病变介入治疗对 1 年预后的影响:随机 IABP-SHOCK II 试验结果。
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):601-609. doi: 10.1177/2048872616668977. Epub 2016 Sep 21.
5
Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.接受直接经皮冠状动脉介入治疗和主动脉内球囊反搏的心源性休克患者的死亡率预测因素。
Med Klin Intensivmed Notfmed. 2016 Nov;111(8):715-722. doi: 10.1007/s00063-015-0118-8. Epub 2015 Nov 23.
6
Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry.急性心肌梗死合并心源性休克患者直接多支血管经皮冠状动脉介入治疗与罪犯病变介入治疗的比较:ALKK-PCI注册研究结果
EuroIntervention. 2015 Jul;11(3):280-5. doi: 10.4244/EIJY14M08_04.
7
Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.急性心肌梗死合并心原性休克患者的性别特异性管理:CULPRIT-SHOCK 试验的亚研究。
Circ Cardiovasc Interv. 2020 Mar;13(3):e008537. doi: 10.1161/CIRCINTERVENTIONS.119.008537. Epub 2020 Mar 10.
8
Current clinical management of acute myocardial infarction complicated by cardiogenic shock.急性心肌梗死合并心原性休克的临床处理现状。
Expert Rev Cardiovasc Ther. 2021 Jan;19(1):41-46. doi: 10.1080/14779072.2021.1854733. Epub 2021 Jan 19.
9
Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.急性心肌梗死合并心源性休克患者的管理趋势及预后
JAMA. 2005 Jul 27;294(4):448-54. doi: 10.1001/jama.294.4.448.
10
Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.多支血管病变与罪犯病变血运重建治疗并发急性心肌梗死后心原性休克:系统评价和荟萃分析。
Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):28-37. doi: 10.1177/2048872617719640. Epub 2017 Jul 13.

引用本文的文献

1
Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.基于糖化血红蛋白 A1c 与载脂蛋白 A1 比值的急性 ST 段抬高型心肌梗死患者主要不良心脏事件预测的列线图模型的建立与验证:一项观察性研究。
Medicine (Baltimore). 2024 Jun 14;103(24):e38563. doi: 10.1097/MD.0000000000038563.

本文引用的文献

1
The global prevalence of myocardial infarction: a systematic review and meta-analysis.全球心肌梗死的患病率:一项系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Apr 22;23(1):206. doi: 10.1186/s12872-023-03231-w.
2
Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.急性 ST 段抬高型心肌梗死合并心原性休克患者行直接经皮冠状动脉介入治疗后院内死亡风险预测列线图。
J Interv Cardiol. 2022 Mar 12;2022:8994106. doi: 10.1155/2022/8994106. eCollection 2022.
3
Incidence, predictors, and clinical outcomes of mechanical circulatory support-related complications in patients with cardiogenic shock.心源牲休克患者机械循环支持相关并发症的发生率、预测因素和临床转归。
J Cardiol. 2022 Feb;79(2):163-169. doi: 10.1016/j.jjcc.2021.08.011. Epub 2021 Sep 10.
4
Acute Kidney Injury in Cardiogenic Shock: An Updated Narrative Review.心源性休克中的急性肾损伤:最新叙述性综述
J Cardiovasc Dev Dis. 2021 Jul 28;8(8):88. doi: 10.3390/jcdd8080088.
5
Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry.心原性休克患者住院死亡率的临床特征和预测因素:RESCUE 登记研究结果。
Circ Heart Fail. 2021 Jun;14(6):e008141. doi: 10.1161/CIRCHEARTFAILURE.120.008141. Epub 2021 Jun 15.
6
Epidemiology and causes of cardiogenic shock.心源性休克的流行病学和病因。
Curr Opin Crit Care. 2021 Aug 1;27(4):401-408. doi: 10.1097/MCC.0000000000000845.
7
Influence of age and shock severity on short-term survival in patients with cardiogenic shock.年龄和休克严重程度对心源性休克患者短期生存的影响。
Eur Heart J Acute Cardiovasc Care. 2021 Aug 24;10(6):604-612. doi: 10.1093/ehjacc/zuaa035.
8
Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients.VA ECMO 支持下心源性休克患者的死亡率:系统评价和荟萃分析评估病因对 29289 例患者的影响。
J Heart Lung Transplant. 2021 Apr;40(4):260-268. doi: 10.1016/j.healun.2021.01.009. Epub 2021 Jan 19.
9
Current clinical management of acute myocardial infarction complicated by cardiogenic shock.急性心肌梗死合并心原性休克的临床处理现状。
Expert Rev Cardiovasc Ther. 2021 Jan;19(1):41-46. doi: 10.1080/14779072.2021.1854733. Epub 2021 Jan 19.
10
Incidence and clinical outcomes of nosocomial infections in patients presenting with STEMI complicated by cardiogenic shock in the United States.美国因心原性休克并发 ST 段抬高型心肌梗死患者的医院感染发生率和临床转归。
Heart Lung. 2020 Nov-Dec;49(6):716-723. doi: 10.1016/j.hrtlng.2020.08.008. Epub 2020 Aug 28.

急性心肌梗死合并心源性休克经皮血管重建术后的院内即时结局

Immediate in-hospital outcomes after percutaneous revascularization of acute myocardial infarction complicated by cardiogenic shock.

作者信息

Solangi Bashir Ahmed, Shah Jehangir Ali, Kumar Rajesh, Batra Mahesh Kumar, Ali Gulzar, Butt Muhammad Hassan, Nisar Ambreen, Qamar Nadeem, Saghir Tahir, Sial Jawaid Akbar

机构信息

Department of Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi 75510, Pakistan.

出版信息

World J Cardiol. 2023 Sep 26;15(9):439-447. doi: 10.4330/wjc.v15.i9.439.

DOI:10.4330/wjc.v15.i9.439
PMID:37900262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10600783/
Abstract

BACKGROUND

Cardiogenic shock (CS) is a life-threatening complication of acute myocardial infarction with high morbidity and mortality rates. Primary percutaneous coronary intervention (PCI) has been shown to improve outcomes in patients with CS.

AIM

To investigate the immediate mortality rates in patients with CS undergoing primary PCI and identify mortality predictors.

METHODS

We conducted a retrospective analysis of 305 patients with CS who underwent primary PCI at the National Institute of Cardiovascular Diseases, Karachi, Pakistan, between January 2018 and December 2022. The primary outcome was immediate mortality, defined as mortality within index hospitalization. Univariate and multivariate logistic regression analyses were performed to identify predictors of immediate mortality.

RESULTS

In a sample of 305 patients with 72.8% male patients and a mean age of 58.1 ± 11.8 years, the immediate mortality rate was found to be 54.8% (167). Multivariable analysis identified Killip class IV at presentation [odds ratio (OR): 2.0; 95% confidence interval (CI): 1.2-3.4; = 0.008], Multivessel disease (OR: 3.5; 95%CI: 1.8-6.9; < 0.001), and high thrombus burden (OR: 2.6; 95%CI: 1.4-4.9; = 0.003) as independent predictors of immediate mortality.

CONCLUSION

Immediate mortality rate in patients with CS undergoing primary PCI remains high despite advances in treatment strategies. Killip class IV at presentation, multivessel disease, and high thrombus burden (grade ≥ 4) were identified as independent predictors of immediate mortality. These findings underscore the need for aggressive management and close monitoring of patients with CS undergoing primary PCI, particularly in those with these high-risk characteristics.

摘要

背景

心源性休克(CS)是急性心肌梗死的一种危及生命的并发症,发病率和死亡率都很高。直接经皮冠状动脉介入治疗(PCI)已被证明可改善CS患者的预后。

目的

研究接受直接PCI的CS患者的即时死亡率,并确定死亡率预测因素。

方法

我们对2018年1月至2022年12月期间在巴基斯坦卡拉奇国家心血管疾病研究所接受直接PCI的305例CS患者进行了回顾性分析。主要结局是即时死亡率,定义为索引住院期间的死亡率。进行单因素和多因素逻辑回归分析以确定即时死亡率的预测因素。

结果

在305例患者的样本中,男性患者占72.8%,平均年龄为58.1±11.8岁,即时死亡率为54.8%(167例)。多变量分析确定,就诊时Killip分级为IV级[比值比(OR):2.0;95%置信区间(CI):1.2 - 3.4;P = 0.008]、多支血管病变(OR:3.5;95%CI:1.8 - 6.9;P < 0.001)和高血栓负荷(OR:2.6;95%CI:1.4 - 4.9;P = 0.003)是即时死亡率的独立预测因素。

结论

尽管治疗策略有所进步,但接受直接PCI的CS患者的即时死亡率仍然很高。就诊时Killip分级为IV级、多支血管病变和高血栓负荷(≥4级)被确定为即时死亡率的独立预测因素。这些发现强调了对接受直接PCI的CS患者进行积极管理和密切监测的必要性,特别是对那些具有这些高危特征的患者。